Iron biology
- PMID: 38658189
- DOI: 10.1093/ndt/gfae095
Iron biology
Abstract
Iron is a fundamental element for biological life, from bacteria to humans. Iron is essential for cell function and survival, energy production and metabolism, whereas increased levels cause oxidative stress. It is also a constituent of haemoglobin and thus it is necessary for oxygen transportation through the body. Given these multiple functions, the regulation of iron metabolism is complex and tight coupled with oxygen homeostasis at tissue and cellular levels, thanks to the interaction with the hypoxia inducible factor system. In patients with chronic kidney disease (CKD), iron deficiency significantly contributes to anaemia development. This frequently overlaps with chronic inflammation, causing iron- restricted erythropoiesis. To add further complexity, metabolic hyperferritinemia may, on one hand, increase the risk for CKD and, on the other, overlaps with functional iron deficiency. Excessive intracellular iron in certain cell types during CKD can also mediate cellular death (called ferroptosis), and contribute to the pathogenesis of kidney damage, atherosclerosis and vascular calcifications. This review is aimed at broadening the perspective of iron metabolism in the setting of CKD not just as a contributor to anaemia in CKD patients, but also as an important player with an impact on cell metabolism, renal fibrosis and the cardiovascular system.
Keywords: anaemia; chronic kidney disease; ferroptosis; iron; metabolic hyperferritinaemia.
© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.
Similar articles
-
Erythropoiesis-independent effects of iron in chronic kidney disease.Pediatr Nephrol. 2022 Apr;37(4):777-788. doi: 10.1007/s00467-021-05191-9. Epub 2021 Jul 9. Pediatr Nephrol. 2022. PMID: 34244852
-
Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.Br J Clin Pharmacol. 2019 May;85(5):935-948. doi: 10.1111/bcp.13877. Epub 2019 Mar 4. Br J Clin Pharmacol. 2019. PMID: 30677788 Free PMC article. Clinical Trial.
-
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.Semin Nephrol. 2016 Jul;36(4):252-61. doi: 10.1016/j.semnephrol.2016.05.002. Semin Nephrol. 2016. PMID: 27475656 Review.
-
Misdistribution of iron and oxidative stress in chronic kidney disease.Free Radic Biol Med. 2019 Mar;133:248-253. doi: 10.1016/j.freeradbiomed.2018.06.025. Epub 2018 Jun 27. Free Radic Biol Med. 2019. PMID: 29958932 Review.
-
Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society Anaemia Group.Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):123-136. doi: 10.1016/j.nefroe.2020.11.011. Epub 2021 May 11. Nefrologia (Engl Ed). 2021. PMID: 36166211 Review.
Cited by
-
Chronic kidney disease.Nat Rev Dis Primers. 2025 Jan 30;11(1):8. doi: 10.1038/s41572-024-00589-9. Nat Rev Dis Primers. 2025. PMID: 39885176 Review.
-
Predictive value of ferritin heavy chains in the development of coronary artery calcification in patients on maintenance hemodialysis: a prospective cohort study.Front Endocrinol (Lausanne). 2025 Jul 30;16:1503940. doi: 10.3389/fendo.2025.1503940. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40810067 Free PMC article.